Blodprov för nyfödda
Heel prick test
Granskad av Dr Colin Tidy, MRCGPSenast uppdaterad av Dr Hayley Willacy, FRCGP Senast uppdaterad 10 feb 2025
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
I denna serie:NyföddhetsscreeningtestNyföddas fysiska undersökningarHörseltest för nyföddaUtvecklingsdysplasi i höftenOdescenderade testiklarBehandling av nyföddas hälsoproblem
Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. This is the blood spot screening programme and it is also known as the heel prick test.
Överblick
The newborn blood spot test is also known as the heel prick test.
A small blood sample is taken from the baby's heel when they are 5 days old.
The test screens for inherited blood disorders and other rare conditions.
These conditions include sickle cell disease, cystic fibrosis and phenylketonuria.
Early diagnosis and treatment can improve outcomes for these conditions.
How is the blood test done?
This is usually done by a health professional (usually a midwife or health visitor) during a home visit when your baby is 5 days old. A very small sample of blood is collected by pricking your baby's heel, using a special device and squeezing out a few drops of blood on to a blood spot card. Although this test may be uncomfortable, it is over very quickly. The sample is sent away for testing, and you will receive the results by letter or phone in due course.
It is important that you tell your healthcare professional if you, your partner or a member of your family have been diagnosed with one of the conditions below.
Which conditions might be tested for by the heel prick test?
Conditions which the heel prick test can screen for are as follows:
Sicklecellanemi (SCD) - this is an inherited blood disorder. Treatment started early in life, can prevent complications. This may include taking regular antibiotics and having extra vaccinations.
Cystisk fibros (CF) - this is an inherited disorder that affects the internal organs, especially the lungs and digestive system. The heel prick test detects a chemical called immunoreactive trypsinogen. This is high in babies with cystic fibrosis. If it is high then a sweat test and genetic test are usually done to confirm the diagnosis. The earlier the diagnosis is made, the sooner treatment can begin which improves the outlook (prognosis).
Phenylketonuria - this is a very rare condition in which the body is unable to break down a substance called phenylalanine, which builds up in the blood and brain. It is really important for this to be picked up early. Early treatment significantly reduces the risk of brain problems and complications in the future.
Congenital hypothyroidism - this is a rare condition which can lead to impaired growth and mental development. However, treated babies can develop normally so it is important for it to be diagnosed early. If your baby was born prematurely (under 32 weeks) then your baby will need a repeat test when they are 28 days old.
Medium-chain acyl-Co-A dehydrogenase deficiency (MCADD)- this is a very rare, but potentially life-threatening, inherited disorder, where fat cannot be broken down by the body as well as usual. Babies with this condition develop normally, but recognising the condition early enables parents to make sure their babies and children with this condition eat regularly. When people with this condition go for a long period of time without eating there is a build-up of medium-chain fats inside the body, which can have a poisonous effect. Also, a sudden and severe drop in blood sugar levels can occur.
All four devolved nations of the United Kingdom now offer screening for four other serious, but treatable, inherited metabolic diseases. These are:
Homocystinuria (HCU).
Maple syrup urine disease (MSUD).
Glutaric aciduria type 1 (GA1).
Isovaleric acidaemia (IVA).
If you do not want your baby to have some or all of these conditions tested for in the heel prick test then you should inform your doctor or midwife.
Patientval för Newborn baby screening tests

Graviditet
Hörseltest för nyfödda
Your baby will be offered a hearing test in the first few weeks after they are born. This is newborn hearing screening. It is a very quick test and does not cause the baby any pain.
av Dr Hayley Willacy, FRCGP

Graviditet
Nyföddas fysiska undersökningar
Your baby will have a head to toe examination by a healthcare professional (usually a doctor) within the first three days (or 72 hours) of birth.
av Dr Hayley Willacy, FRCGP
Vanliga frågor
What specifically does the heel prick test check for?
The heel prick test screens for several serious conditions including Sickle Cell Disease (SCD), Cystic Fibrosis (CF), Phenylketonuria, Congenital Hypothyroidism, and Medium-chain acyl-Co-A dehydrogenase deficiency (MCADD). It also screens for four additional inherited metabolic diseases: Homocystinuria (HCU), Maple Syrup Urine Disease (MSUD), Glutaric Aciduria type 1 (GA1), and Isovaleric Acidaemia (IVA).
Vidare läsning och referenser
- Postpartum care; NICE Guidance (April 2021)
- Program för befolkningsscreening (England); GOV.UK
- Nyföddhetsscreening; NI Direct Government Services
- Newborn bloodspot screening NHS Scotland
- Newborn Bloodspot Screening Wales
Om recensentenVisa fullständig biografi

Dr Colin Tidy, MRCGP
Allmänläkare, Medicinsk Författare
MBBS, MRCGP, MRCP (Paediatrics), DCH
Dr Colin Tidy är en NHS-läkare, baserad i Oxfordshire.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning: 9 feb 2028
10 feb 2025 | Senaste versionen
Medicinska yrkesverksamma
Looking for more in-depth clinical detail? Our Professional Reference articles are written for doctors, nurses and other healthcare professionals. They include comprehensive clinical guidance, diagnostic information and UK/European evidence summaries. If you need the clinical version, you can read the Professional Reference article on this topic.
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.


